Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
BCL2 D103Y
i
Other names:
BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Associations
(2)
News
Trials
C3 | Sensitive
C3 | Resistant
Show legend
Drug categories
BCL Inhibitors
CD Protein Inhibitors
Immunotherapy
Cancel
Chronic Lymphocytic Leukemia
venetoclax + obinutuzumab
C3
BCL2 D103Y
|
Chronic Lymphocytic Leukemia
|
venetoclax + obinutuzumab
venetoclax + rituximab
C3
BCL2 D103Y
|
Chronic Lymphocytic Leukemia
|
venetoclax + rituximab
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login